Table 26:
# Studies (Design) | Risk of Bias | Inconsistency | Indirectness | Imprecision | Publication Bias | Upgrade Considerations | Quality |
---|---|---|---|---|---|---|---|
2 RCTs | Serious limitations (−1)a | Serious limitations (−1)b | No serious limitations | No serious limitations | Undetected | None | ⊕⊕ Low |
4 non-RCTs | Serious limitations (−1)c | Serious limitations (−1)b | No serious limitations | Serious limitations (−1)d | Undetected | None | ⊕ Very low |
Abbreviations: GRADE, Grading of Recommendations Assessment, Development, and Evaluation; RCT, randomized controlled trial.
No intention-to-treat analysis.
Inconsistent (nonsignificant vs. significant) results.
Nonrandomized studies start at low GRADE. Differences in baseline patient, cancer, or surgeon characteristics may impact potency outcomes without adjustment.
Use of nonvalidated and possibly subjective outcome measures in some studies for dichotomous potency outcomes. Nonstandardized reporting within studies makes it difficult to directly compare studies.